MedPath

Induction chemotherapy followed by radiotherapy in locally advanced head and neck cancers.

Phase 2
Conditions
Health Condition 1: C01- Malignant neoplasm of base of tongue
Registration Number
CTRI/2023/08/056851
Lead Sponsor
Department of Radiotherapy and Radiation Medicine,
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Open to Recruitment
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1)Histologically proven oropharynx, larynx, hypopharynx cancer

2)Stage III-IV

3)Squamous cell carcinoma

4) ECOG 0-1

Exclusion Criteria

1) Previously treated Head and Neck Malignancy

2) Pregnant Lactating Females

3) Received chemotherapy and radiotherapy earlier

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1)loco regional control <br/ ><br>2) Acute toxicity <br/ ><br>3) quality of LifeTimepoint: 6 months
Secondary Outcome Measures
NameTimeMethod
1) overall survival <br/ ><br>2) Disease free survival <br/ ><br>3)late toxictyTimepoint: 6 months
© Copyright 2025. All Rights Reserved by MedPath